- Home
- VLTO vs IQV Comparison
VLTO vs IQV Comparison
Compare VLTO & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLTO
- IQV
- Stock Information
- Founded
- VLTO 2023
- IQV 1982
- Country
- VLTO United States
- IQV United States
- Employees
- VLTO N/A
- IQV N/A
- Industry
- VLTO Electrical Products
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- VLTO Industrials
- IQV Health Care
- Exchange
- VLTO Nasdaq
- IQV Nasdaq
- Market Cap
- VLTO 26.5B
- IQV 31.0B
- IPO Year
- VLTO N/A
- IQV 2013
- Fundamental
- Price
- VLTO $105.72
- IQV $187.76
- Analyst Decision
- VLTO Buy
- IQV Strong Buy
- Analyst Count
- VLTO 7
- IQV 19
- Target Price
- VLTO $114.00
- IQV $229.37
- AVG Volume (30 Days)
- VLTO 931.3K
- IQV 1.2M
- Earning Date
- VLTO 10-22-2025
- IQV 10-30-2025
- Dividend Yield
- VLTO 0.42%
- IQV N/A
- EPS Growth
- VLTO 12.21
- IQV N/A
- EPS
- VLTO 3.58
- IQV 6.92
- Revenue
- VLTO $5,362,000,000.00
- IQV $15,700,000,000.00
- Revenue This Year
- VLTO $8.01
- IQV $6.01
- Revenue Next Year
- VLTO $5.46
- IQV $5.05
- P/E Ratio
- VLTO $29.53
- IQV $27.11
- Revenue Growth
- VLTO 5.61
- IQV 3.60
- 52 Week Low
- VLTO $83.87
- IQV $134.65
- 52 Week High
- VLTO $115.00
- IQV $249.54
- Technical
- Relative Strength Index (RSI)
- VLTO 47.56
- IQV 53.87
- Support Level
- VLTO $104.00
- IQV $177.82
- Resistance Level
- VLTO $107.82
- IQV $192.13
- Average True Range (ATR)
- VLTO 1.43
- IQV 4.48
- MACD
- VLTO -0.45
- IQV -1.14
- Stochastic Oscillator
- VLTO 28.15
- IQV 54.02
About VLTO Veralto Corp
Veralto is a diversified industrial firm organized into two segments, water quality as well as product quality and innovation. The water quality segment offers water analytics and water treatment solutions, while the product quality and innovation segment offers coding, packaging, and color solutions for consumer packaged goods and pharmaceuticals. Headquartered in Waltham, Massachusetts, the company has around 17,000 employees. Veralto generated approximately $5.2 billion in revenue in 2024.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.